Danaher Corp (DHR) concluded trading on Wednesday at a closing price of $237.97, with 4.12 million shares of worth about $979.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.62% during that period and on January 15, 2025 the price saw a gain of about 0.15%. Currently the company’s common shares owned by public are about 722.20M shares, out of which, 692.96M shares are available for trading.
Stock saw a price change of -0.47% in past 5 days and over the past one month there was a price change of 1.48%. Year-to-date (YTD), DHR shares are showing a performance of 3.67% which increased to 5.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $222.53 but also hit the highest price of $281.70 during that period. The average intraday trading volume for Danaher Corp shares is 3.11 million. The stock is currently trading 2.07% above its 20-day simple moving average (SMA20), while that difference is up 0.75% for SMA50 and it goes to -6.15% lower than SMA200.
Danaher Corp (NYSE: DHR) currently have 722.20M outstanding shares and institutions hold larger chunk of about 80.67% of that.
The stock has a current market capitalization of $171.88B and its 3Y-monthly beta is at 0.84. PE ratio of stock for trailing 12 months is 45.39, while it has posted earnings per share of $5.24 in the same period. Its PEG reads 6.10 and has Quick Ratio of 1.01 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DHR, volatility over the week remained 2.90% while standing at 2.07% over the month.
Stock’s fiscal year EPS is expected to drop by -1.14% while it is estimated to increase by 9.99% in next year. EPS is likely to shrink at an annualized rate of 7.44% for next 5-years, compared to annual growth of 11.31% made by the stock over the past 5-years.
Coverage by Guggenheim stated Danaher Corp (DHR) stock as a Buy in their note to investors on December 19, 2024, suggesting a price target of $275 for the stock. On December 13, 2024, BofA Securities Upgrade their recommendations, while on October 31, 2024, Wolfe Research Upgrade their ratings for the stock with a price target of $285. Stock get an Overweight rating from Stephens on October 01, 2024.
